КОХЛЕВЕСТИБУЛЯР БУЗИЛИШЛАРНИНГ АРТЕРИАЛ ГИПЕРТОНИЯ БЎЛГАН БЕМОРЛАРДА АУДИОМЕТРИЯ НАТИЖАЛАРИ
##semicolon##
Калит сўзлар: кохлеовестибуляр бузилиш, эшитиш пастлиги, ОАЭ.Abstrak
Аннотация. Ушбу мақолада авторлар томонидан артериал гипертония
касаллиги фонида кохлеовестибуляр бузилишларнинг аудиологик тавсифи ва
текширув натижалари таҳлиллари келтирилган. Жаҳон статистик
маълумотларига кўра, 2019 йилда дунё бўйлаб 460 миллиондан ортиқ одам
эшитиш қобилиятини йўқотган ва 2050 йилга келиб уларнинг сони 900
миллиондан ошиши мумкин. Бир қатор хорижий муаллифларнинг фикрига кўра,
кохлеовестибуляр бузилишлар (КВБ) учун характерли шикоятлар ЛОР
шифокорига мурожаат қилган беморларнинг тахминан 10% ни ва умумий
амалиёт шифокори учун бу кўрсаткич 5%, невролог учун эса 10-20%ни ташкил
қилади. Бош айланиши беморлар томонидан умумий амалиёт шифокорига
кўрсатилган энг кўп учрайдиган учта шикоятдан бири бўлиб, шошилинч
маслаҳатлар орасида беморларнинг 2,4-2,6 фоизида учрайди.
##submission.citations##
Фойдаланилган адабиётлар рўйхати:
1. Attyé A., Eliezer M. Endolymph magnetic resonance imaging: Contribution of
saccule and utricle analysis in the management of patients with sensorineural ear
disorders //European Annals of Otorhinolaryngology, Head and Neck Diseases.
– 2020. – Т. 137. – №. 1. – С. 47-51.
2. Bae S. H. et al. Is the cochleovestibular nerve function affected in patients with
hemifacial spasm? //Acta Neurologica Belgica. – 2021. – С. 1-5.
3. Chebib E. et al. Predictors of cochleovestibular dysfunction in children with
congenital cytomegalovirus infection //European Journal of Pediatrics. – 2022.
– С. 1-10.
4. Ciorba A. et al. Autoimmune inner ear disease (AIED): a diagnostic challenge
//International journal of immunopathology and pharmacology. – 2018. – Т. 32.
– С. 2058738418808680.
5. Eyermann C. et al. Cochleovestibular manifestations in Fabry disease:
Importance of screening and systematic ENT evaluation //European Annals of
Otorhinolaryngology, Head and Neck Diseases. – 2019. – Т. 136. – №. 4. – С.
273-279.
6. Fatma M. et al. Cochleo-vestibular disorders in diabetic patients //Endocrine
Abstracts. – Bioscientifica, 2022. – Т. 81.
7. Khoza-Shangase K. Cochleovestibular findings linked to COVID-19: A scoping
review for clinical care planning in South Africa //South African Journal of
Communication Disorders. – 2022. – Т. 69. – №. 2. – С. 899.
8. Kryukov A. I. et al. A case of hearing preservation during surgical treatment of
distributed fistula labyrinth in a patient with chronic purulent means otitis and
cholesteatoma //Vestnik otorinolaringologii. – 2022. – Т. 87. – №. 3. – С. 99-
106.
9. Lemasson J. et al. Cochleovestibular toxicity induced by immune checkpoint
inhibition: a case series //European Journal of Cancer. – 2019. – Т. 117. – С.
116-118.
10. McNeill A. et al. SLC12A2 variants cause a neurodevelopmental disorder or
cochleovestibular defect //Brain. – 2020. – Т. 143. – №. 8. – С. 2380-2387.
11. Neri G. et al. Assessment of the effect of mesoglycan in the treatment of
audiovestibular disorders of vascular origin //International Journal of
Immunopathology and Pharmacology. – 2018. – Т. 32. – С. 2058738418773833.
12. Sluydts M. et al. The relationship between cochleovestibular function tests and
endolymphatic hydrops grading on MRI in patients with Menière’s disease
//European Archives of Oto-Rhino-Laryngology. – 2021. – Т. 278. – №. 12. –
С. 4783-4793.
13. Tardov M. V., Igor’V D. Cochleovestibular disorders: clinical and pathogenetic
aspects //Medical Journal of the Russian Federation. – 2020. – Т. 26. – №. 3. –
С. 188-194.
14. Zh R. A., Abdukayumov A. A. INDICATORS OF COCHLEOVESTIBULAR
DISORDERS IN CHRONIC SUPPURATIVE OTITIS MEDIA //E Conference
Zone. – 2022. – С. 88-89.
